← Back to Screener
Autonomix Medical, Inc. Common Stock (AMIX)
Price$0.41
Favorite Metrics
Price vs S&P 500 (26W)-70.90%
Price vs S&P 500 (4W)-17.87%
Market Capitalization$4.61M
All Metrics
Book Value / Share (Quarterly)$0.75
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-1.04
Price vs S&P 500 (YTD)-29.24%
EPS (TTM)$-3.98
10-Day Avg Trading Volume0.10M
EPS Excl Extra (TTM)$-3.98
EPS (Annual)$-6.46
ROI (Annual)-140.88%
Cash / Share (Quarterly)$0.87
ROA (Last FY)-116.36%
EBITD / Share (TTM)$-3.46
Cash Flow / Share (Annual)$-3.31
P/B Ratio0.54x
P/B Ratio (Quarterly)0.44x
Net Income / Employee (Annual)$-1
ROA (TTM)-186.65%
EPS Incl Extra (Annual)$-6.46
Current Ratio (Annual)5.63x
Quick Ratio (Quarterly)6.18x
3-Month Avg Trading Volume2.29M
52-Week Price Return-75.29%
Revenue / Employee (TTM)$0
52-Week High$2.82
EPS Excl Extra (Annual)$-6.46
26-Week Price Return-66.91%
Quick Ratio (Annual)5.63x
13-Week Price Return-20.08%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)6.18x
Enterprise Value$-5.328
Revenue / Employee (Annual)$0
Cash / Share (Annual)$3.66
3-Month Return Std Dev71.35%
Net Income / Employee (TTM)$-2
ROE (Last FY)-140.88%
EPS Basic Excl Extra (Annual)$-6.46
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-3.98
ROI (TTM)-228.82%
Revenue / Share (Annual)$0.00
Price vs S&P 500 (52W)-105.12%
Year-to-Date Return-26.60%
5-Day Price Return0.95%
EPS Normalized (Annual)$-6.46
Month-to-Date Return3.49%
EBITD / Share (Annual)$-6.46
LT Debt / Equity (Annual)0.00x
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-3.98
P/B Ratio (Annual)0.53x
Book Value / Share (Annual)$3.24
Price vs S&P 500 (13W)-20.76%
Beta1.19x
Revenue / Share (TTM)$0.00
ROE (TTM)-228.82%
52-Week Low$0.34
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.25
4.25
4.25
4.25
Industry Peers — Surgical & Medical Instruments(109)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
AMIXAutonomix Medical, Inc. Common Stock | — | — | — | — | $0.41 |
SYKStryker Corporation | 5.15x | 11.84% | 64.57% | 19.43% | $338.38 |
BSXBoston Scientific Corp. | 4.76x | 15.16% | 69.01% | 18.00% | $63.42 |
MMM3M Company | 3.18x | -4.97% | 39.92% | 18.55% | $150.55 |
MDLNMedline Inc. Class A common stock | 2.21x | — | 26.44% | 7.78% | $46.94 |
BDXBecton, Dickinson and Co. | 2.01x | 6.32% | 46.42% | 12.15% | $154.82 |
RMDResMed Inc. | 6.06x | 11.72% | 60.85% | 33.70% | $224.72 |
DXCMDexCom, Inc. | 5.23x | 19.33% | 62.09% | 19.56% | $61.23 |
WSTWest Pharmaceutical Services, Inc. | 6.22x | 7.44% | 35.91% | 19.03% | $269.81 |
PODDInsulet Corporation | 5.31x | 24.53% | 71.63% | 12.92% | $201.47 |
PENPenumbra, Inc. | 9.31x | 20.16% | 67.14% | 13.48% | $331.47 |
About
Autonomix Medical is a development-stage company developing a first-in-class, catheter-based neural sensing platform designed to detect and treat nervous system disorders. The company's microchip-enabled array has demonstrated high-sensitivity neural signal detection and differentiation in animal studies.